Table 1.

SLE patient demographics, clinical parameters, medications and disease characteristics including SLEDAI score.

Age, Mean (SD)	Sex, Female/Male	Ethnicity	ESR	CRP	ANA	Anti-dsDNAab	SLEDAI	Medications
38.5 (15.27)	Female (78.65%) Male (21.45%)	Asian (14.3%) Hispanic (21.4%), White (64.3%)	38.5 (15.3)	0.60 (0.28)	8/14+ ve	368.4 (317.5)	6.57 (3.20)	Patients were on prednisone, hydroxychloroquine, methotrexate, plaquenil, Imuran, folic acid, Vitamin D, topomax Cellcept (mycophenolate mofetil), furosemide

Data are presented as medians, means (SD) or number (%) as indicated. Age range was between 20-72 years, ESR (Erythrocyte sedimentation rate) range was 3-31, CRP (C- reactive protein) range was in between 0.5-1.5, ANA (Anti-nuclear antibody) was positive in 8 patients out of 14. 6 had < 1:40, Anti-dsDNA Ab (Anti-double strand DNA Ab) range was between 200-1243, SLEDAI (SLE disease activity index) range was between1-10. Medications listed are for all the combined patients. Healthy controls had similar demographics including age range and had no medications at the time of blood draw.